drug · antibody
patient view →mogamulizumab
Marketedupdated 2mo agoby Kyowa Kirin Co Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 5 investigational indications.
targets
C-C chemokine receptor type 4
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that